Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Warner Bros. Discovery, Inc.DISCA · Entity 2976 | Chief Commercial Officer | August 18, 2017 | August 22, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Warner Bros. Discovery, Inc.
Report date August 18, 2017 · Filed August 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Common StockSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
After 2017-08-18 transaction · row 1
1 source rowRow 1 · 2017-08-18 · Purchase · Acquired 10,000 · Balance 10,000 F1: The price reported represents the weighted average purchase price of shares of Series A common stock purchased in multiple transactions at prices ranging from $22.685 to $22.720 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported represents the weighted average purchase price of shares of Series A common stock purchased in multiple transactions at prices ranging from $22.685 to $22.720 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NUTRI SYSTEM INC /DE/
Report date March 08, 2019 · Filed March 11, 2019
Section 16 reporting ended · disclosed 2019-03-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 1
1 source rowRow 1 · 2019-03-08 · Disposition to issuer · Disposed 34,279 · Balance 0 F1: As of the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health, each share of the Issuer's common stock, $0.001 par value per share, held by the Reporting Person was converted into the right to receive (i) $38.75 in cash and (ii) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: As of the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health, each share of the Issuer's common stock, $0.001 par value per share, held by the Reporting Person was converted into the right to receive (i) $38.75 in cash and (ii) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2019 Filed Mar 11, 2019 14:52 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Disposition to issuerCommon Stock | 34,279 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018367 · doc4.xml · nonDerivative · entry 1 GUAGLIARDO PAUL J · CIK 0001282691 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: As of the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health, each share of the Issuer's common stock, $0.001 par value per share, held by the Reporting Person was converted into the right to receive (i) $38.75 in cash and (ii) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock. Read SEC document |
| May 09, 2018 Filed May 11, 2018 16:06 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon stock | 4,114 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-029520 · doc4.xml · nonDerivative · entry 1 GUAGLIARDO PAUL J · CIK 0001282691 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,279 F1 · shares: Restricted shares were granted on May 9, 2018 pursuant to a Director compensation policy. Shares are fully vested on date of grant but are restricted from sale for one year. F2 · price: Shares granted as compensation as Director/price per share on day of grant $31.60. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 12:07 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GiftCommon stock | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066939 · doc4.xml · nonDerivative · entry 1 GUAGLIARDO PAUL J · CIK 0001282691 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,165 Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 21:04 UTC | Warner Bros. Discovery, Inc. DISCA · Entity 2976 | PurchaseSeries A Common Stock | 10,000 | $22.71 | $227,060.00 |
DisclosureSEC source: 0001209191-17-049833 · doc4.xml · nonDerivative · entry 1 GUAGLIARDO PAUL J · CIK 0001282691 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported represents the weighted average purchase price of shares of Series A common stock purchased in multiple transactions at prices ranging from $22.685 to $22.720 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| May 10, 2017 Filed May 12, 2017 14:55 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon stock | 2,012 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-031831 · doc4.xml · nonDerivative · entry 1 GUAGLIARDO PAUL J · CIK 0001282691 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,215 F1 · shares: Restricted shares were granted on May 10, 2017 pursuant to a Director compensation policy. Shares are fully vested on date of grant but are restricted from sale for one year. F2 · price: Shares granted as compensation as Director/price per share on day of grant $49.70. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:41 UTC | Warner Bros. Discovery, Inc. DISCA · Entity 2976 | GrantEmployee Stock Option (right to acquire) · Derivative | 174,678 | $0.00 Strike: $29.50 | $0.00 |
DisclosureSEC source: 0001209191-17-014950 · doc4.xml · derivative · entry 1 GUAGLIARDO PAUL J · CIK 0001282691 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,678 Underlying: Series A Common Stock · 174,678 shares Expires 2024-02-23 F1 · derivative.exercise_date: This option vests in four equal annual installments beginning February 23, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.